trial · primary record
Rilpivirine
Human Immunodeficiency Virus Type 1
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2026-08-18 |
| Primary endpoint | Number of participants with adverse events (AEs) related to rilpivirine (RPV) |
| Registry ID | NCT02494986 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:43.547Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02494986
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.